The role of artificial intelligence in providing accurate and reliable information on surgically-assisted rapid palatal expansion: A cross-sectional study

Jun 27, 2026 by in CARDIOLOGY Comments Off on The role of artificial intelligence in providing accurate and reliable information on surgically-assisted rapid palatal expansion: A cross-sectional study
Introduction This study aimed to evaluate the accuracy, reliability, and comprehensibility of information about surgically-assisted rapid palatal expansion provided by language models based on artificial intelligence (AI). Methods A cross-sectional…
read more

An objective method for assessing the maturation of bone sutures involved in the rapid maxillary expansion

Jun 27, 2026 by in CARDIOLOGY Comments Off on An objective method for assessing the maturation of bone sutures involved in the rapid maxillary expansion
Introduction This study aimed to evaluate the maturation of the midpalatal suture (MPS), zygomaticomaxillary suture, and zygomaticotemporal suture (ZTS) (right and left) through density by multislice computed tomography in patients…
read more

Cerebral embolic protection devices for transcatheter aortic valve replacement: A meta-analysis and trial sequential analysis

Jun 27, 2026 by in CARDIOLOGY Comments Off on Cerebral embolic protection devices for transcatheter aortic valve replacement: A meta-analysis and trial sequential analysis
Highlights • Routine use of current-generation CEPD was not associated with any difference in the incidence of any stroke, disabling stroke or all-cause mortality. • Trial sequential analysis indicates that,…
read more

Serial assessment of NT-proBNP and high-sensitivity cardiac troponin with glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes: Insights from EXSCEL

Jun 27, 2026 by in CARDIOLOGY Comments Off on Serial assessment of NT-proBNP and high-sensitivity cardiac troponin with glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes: Insights from EXSCEL
ABSTRACT Background In the EXSCEL trial, exenatide did not reduce major adverse cardiovascular events (MACE), but heterogeneity of benefit and the role of cardiac biomarkers remain uncertain. We evaluated the…
read more

Association between hospital ownership type and ST-segment elevation myocardial infarction outcomes: Insights from the National Readmission Database, 2016-2022

Jun 27, 2026 by in CARDIOLOGY Comments Off on Association between hospital ownership type and ST-segment elevation myocardial infarction outcomes: Insights from the National Readmission Database, 2016-2022
Highlights • Patients with STEMI at for-profit and public hospitals had greater socioeconomic needs than those at nonprofit hospitals. • For-profit hospitals had worse in-hospital mortality and 90-day readmission outcomes…
read more

Short-term outcomes of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction: A randomized pilot study

Jun 27, 2026 by in CARDIOLOGY Comments Off on Short-term outcomes of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction: A randomized pilot study
ABSTRACT Background Ticagrelor monotherapy after a short period of dual antiplatelet therapy (DAPT) has shown to be safe and effective after percutaneous coronary intervention (PCI), including primary PCI in ST-elevation…
read more

Secondary prevention strategies for patients with lower extremity peripheral artery disease after successful peripheral vascular intervention

Jun 27, 2026 by in CARDIOLOGY Comments Off on Secondary prevention strategies for patients with lower extremity peripheral artery disease after successful peripheral vascular intervention
Highlights • Lower extremity peripheral artery disease carries a high risk of subsequent morbidity and mortality, requiring aggressive secondary prevention therapies. • Secondary prevention therapies are particularly underutilized in the…
read more

PIONEER IV trial: Update in study protocol

Jun 27, 2026 by in CARDIOLOGY Comments Off on PIONEER IV trial: Update in study protocol
The PIONEER IV trial (NCT04923191) is a prospective, all-comers, multi-centre trial, planned to randomize 2,540 patients in a 1:1 ratio to percutaneous coronary intervention (PCI) guided by angiography-derived physiology or…
read more
Get Clinical Tree app for offline access